Ibex Investors’s Varian Medical Systems, Inc. VAR Stock Holding History

Ibex Investors’s Portfolio VAR Stock Details VAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-2,527	Closed	-$310K	–	264
2018 Q1	$310K	Buy	+2,527	New	+$301K	0.26%	57

Other funds holding VAR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Ibex Investors's VAR Position: Q2 2018 in Review

Ibex Investors sold out of Varian Medical Systems, Inc. (VAR) in Q2 2018, closing a stake of 2,527 shares — an estimated $310K sold.

Ibex Investors first reported a position in VAR in Q1 2018 and held it in 1 quarter. The position peaked at $310K in Q1 2018. 587 funds tracked by Wall St. Rank hold VAR as of Q2 2018.

Ibex Investors reported no remaining Varian Medical Systems, Inc. position as of Q2 2018 after selling out during the quarter.
Ibex Investors sold 2,527 Varian Medical Systems, Inc. shares in Q2 2018, an estimated $310K.
Ibex Investors first reported a position in Varian Medical Systems, Inc. in Q1 2018 and held it in 1 quarter.
Ibex Investors's Varian Medical Systems, Inc. position peaked at $310K in Q1 2018.
587 funds tracked by Wall St. Rank held Varian Medical Systems, Inc. as of Q2 2018.

Based on Ibex Investors's 13F filing for Q2 2018, filed 14 Aug 2018.